Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonistic CD28 antigen binding molecules targeting Her2

Agonistic CD28 antigen binding molecules targeting Her2

US Patent 12049515 · Granted Jul 30, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antibody molecules binding to CD3 and EGFRvIII2025
Bispecific antibody molecules binding to CD3 and EGFRvIII2025
Anti-HLA-G antibodies and use thereof2025
Methods of treating cancer by administering tumor necrosis factor (TNF) family l2025
Methods of treating cancer by administering tumor necrosis factor (TNF) family l2025
Use of a cathepsin s inhibitor against the formation of anti-drug antibodies2025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific antibodies specific for PD1 and TIM32025
Bispecific anti-human A-beta/anti-human transferrin receptor antibodies2025
Methods to determine antibody activity in tumor samples2025
Trispecific antibodies specific for HER2 and a blood brain barrier receptor and 2025
Bispecific antigen-binding molecules and methods of use2025